ÂÜÀòÂÒÂ×

David Needham is a Professor Emeritus at Duke University, with a career that spans over three decades focused on the research and development of drug formulations, particularly targeting cancer therapies and respiratory virus treatments. Current roles include serving as the Chief Scientific Officer at DNKO, Professor of Translational Therapeutics at the University of Nottingham, and ongoing contributions to DartSight Ltd as an inventor and educator. Additionally, Professor Needham held the Niels Bohr Professorship at the University of Southern Denmark, where efforts centered on establishing a new center for Single Particle Science. Needham's academic background includes a PhD in Physical Chemistry from the University of Nottingham and several postdoctoral positions, leading to notable advancements in drug delivery systems and nanoparticle formulations.